logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India | Journal Article / Research | MSF Science Portal
Journal Article
|Research

Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India

Isaakidis P, Varghese B, Mansoor H, Cox HS, Ladomirska J, Saranchuk P, Da Silva E, Paryani R, Udwadia ZF, Migliori GB, Sotgiu G, Reid AJ
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB). However, there is little prospective data on AE in MDR- or XDR-TB/HIV co-infected patients on antituberculosis and antiretroviral therapy (ART) in programmatic settings.

Countries

India

Subject Area

antibiotic resistancetuberculosisantimicrobial resistanceHIV/AIDS

Languages

English
DOI
10.1371/journal.pone.0040781
Published Date
11 Jul 2011
PubMed ID
22792406
Journal
PLOS One
Volume | Issue | Pages
Volume 7, Issue 7
Issue Date
2012-07-11
Dimensions Badge